HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phase III clinical trial (AK112-312/HARMONi-GI6) of ivonescimab in first-line treatment for advanced metastatic colorectal cancer (mCRC).
kAm%9:D C2?5@>:K65[ 4@?EC@==65[ >F=E:\46?E6C !92D6 xxx 4=:?:42= EC:2= 7@C 7:CDE\=:?6 EC62E>6?E @7 >r#r :D @?6 @7 E96 4@>A2?JVD <6J :?:E:2E:G6D E@ 255C6DD E96 D:8?:7:42?E F?>6E 4=:?:42= ?665 H@C=5H:56 H:E9 :G@?6D4:>23]k^Am
kAmr@=@C64E2= 42?46C C6>2:?D E96 E9:C5 >@DE 4@>>@? 42?46C 8=@32==J 2?5 E96 D64@?5 =625:?8 42FD6 @7 42?46C\C6=2E65 562E9D] x? a_aa[ @G6C `]h >:==:@? ?6H 42D6D H6C6 C6A@CE65[ H:E9 2AAC@I:>2E6=J h_c[___ 562E9D] ~7 E96D6[ 23@FE hdT @7 >r#r 42D6D 2C6 4=2DD:7:65 2D >:4C@D2E6==:E6 DE23=6 W|$$X @C AC@7:4:6?E >:D>2E49 C6A2:C WA||#X[ H9:49 EC25:E:@?2==J D9@H A@@C C6DA@?D6D E@ :>>F?@E96C2AJ 2?5 E96 EF>@CD 2C6 @7E6? C676CC65 E@ 2D 2? Q:>>F?6 56D6CE]Qk^Am
kAmu@C 7:CDE\=:?6 EC62E>6?E @7 |$$^A||#\EJA6 >r#r[ H9:49 C6AC6D6?ED FA E@ hdT @7 42D6D[ D6G6C2= !s\`^{` :?9:3:E@CD 92G6 366? 6IA=@C65 :? >F=E:A=6 :?E6C?2E:@?2= DEF5:6D] w@H6G6C[ E96 677:424J 92D 366? =:>:E65[ 2?5 2D @7 ?@H[ ?@ 7:CDE\=:?6 :>>F?@E96C2AJ 92D 366? 2AAC@G65 8=@32==J 7@C A2E:6?ED H:E9 A||#^|$$\EJA6 >r#r]k^Am
kAmr96>@E96C2AJ 4@>3:?65 H:E9 E2C86E65 E96C2A:6D WDF49 2D 36G24:KF>23[ 46EFI:>23[ 6E4]X C6>2:?D E96 DE2?52C5 7:CDE\=:?6 EC62E>6?E 7@C >r#r[ E9@F89 :ED @G6C2== 677:424J :D =:>:E65[ H:E9 2 7:G6\J62C DFCG:G2= C2E6 7@C 25G2?465 A2E:6?ED @7 =6DD E92? a_T] q6G24:KF>23 :D E96 >@DE H6==\6DE23=:D965 2?5 4=:?:42==J :>A24E7F= EC62E>6?E :? E96 >r#r DA246] xE :D 2=D@ @?6 @7 E96 4@C6 :?5:42E:@?D @7 36G24:KF>23]k^Am
kAmpE E96 a_ac tFC@A62? $@4:6EJ 7@C |65:42= ~?4@=@8J Wt$|~X r@?8C6DD[ !C@76DD@C kDA2? 4=2DDlQI?\A6CD@?Qm*2?9@?8 s6?8k^DA2?m 7C@> E96 $:IE9 p77:=:2E65 w@DA:E2= @7 kDA2? 4=2DDlQI?\A6CD@?Qm$F? *2Ek^DA2?m\D6? &?:G6CD:EJ[ AC6D6?E65 AC@>:D:?8 !92D6 xx 677:424J 52E2 @7 :G@?6D4:>23 :? 4@>3:?2E:@? H:E9 496>@E96C2AJ 7@C 7:CDE\=:?6 EC62E>6?E @7 |$$^A||#\EJA6 >r#r]k^Am
kAm%96 4@>3:?2E:@? @7 :G@?6D4:>23 H:E9 u~{u~)x#x 56>@?DEC2E65 4@>A6==:?8 2?E:\EF>@C 24E:G:EJ :? E9:D 92C5 E@ EC62E A2E:6?E A@AF=2E:@?[ H:E9 2? @G6C2== C6DA@?D6 C2E6 W~##X @7 g`]gT 2?5 2 5:D62D6 4@?EC@= C2E6 Wsr#X @7 `__T] p7E6C 2 >65:2? 7@==@H\FA @7 h >@?E9D[ E96 >65:2? AC@8C6DD:@?\7C66 DFCG:G2= W>!u$X H2D ?@E C624965[ H:E9 2 h\>@?E9 !u$ C2E6 @7 g`]cT] #682C5=6DD @7 z#p$^q#pu >FE2E:@? DE2EFD[ A2E:6?ED 42? 36?67:E 7C@> :G@?6D4:>23 4@>3:?2E:@? E96C2AJ]k^Am
kAm%96 C6DF=ED AF3=:D965 2E E96 a_ac t$|~ DF886DE E92E :G@?6D4:>23 >2J @776C 2 D:8?:7:42?E :>AC@G6>6?E @G6C 6I:DE:?8 EC62E>6?E @AE:@?D 7@C |$$^A||# >r#r A2E:6?ED] %96 !92D6 xxx EC:2= pz``a\b`a^wp#|~}:\vxe 42? A@E6?E:2==J 7FCE96C G2=:52E6 E96 4=:?:42= 36?67:ED @7 :G@?6D4:>23 :? E9:D D6EE:?8[ @776C:?8 2 ?@G6= 7:CDE\=:?6 :>>F?@E96C2AJ EC62E>6?E @AE:@? 7@C A2E:6?ED H:E9 25G2?465 >r#r]k^Am
kAmkDEC@?8mu@CH2C5\{@@<:?8 $E2E6>6?E @7 p<6D@[ x?4]k^DEC@?8mk^Am
kAm%9:D 2??@F?46>6?E 3J p<6D@[ x?4] Whhae]wz[ Qp<6D@QX 4@?E2:?D Q7@CH2C5\=@@<:?8 DE2E6>6?EDQ] %96D6 DE2E6>6?ED C67=64E E96 4FCC6?E 36=:67D 2?5 6IA64E2E:@?D @7 p<6D@VD >2?286>6?E 2?5 2C6 DF3;64E E@ D:8?:7:42?E C:D<D 2?5 F?46CE2:?E:6D] %96D6 DE2E6>6?ED 2C6 ?@E :?E6?565 E@ 7@C> E96 32D:D @7 2?J :?G6DE>6?E 564:D:@? @C 2?J 564:D:@? E@ AFC492D6 D64FC:E:6D @7 p<6D@] %96C6 42? 36 ?@ 2DDFC2?46 E92E E96 5CF8 42?5:52E6WDX :?5:42E65 :? E9:D 2??@F?46>6?E @C p<6D@VD @E96C A:A6=:?6 42?5:52E6D H:== @3E2:? E96 C6BF:C65 C68F=2E@CJ 2AAC@G2=D @C 249:6G6 4@>>6C4:2= DF446DD] x7 F?56C=J:?8 2DDF>AE:@?D AC@G6 :?244FC2E6 @C C:D<D @C F?46CE2:?E:6D >2E6C:2=:K6[ 24EF2= C6DF=ED >2J 5:776C >2E6C:2==J 7C@> E9@D6 D6E 7@CE9 :? E96 7@CH2C5\=@@<:?8 DE2E6>6?ED]k^Am
kAm#:D<D 2?5 F?46CE2:?E:6D :?4=F56 3FE 2C6 ?@E =:>:E65 E@[ 86?6C2= :?5FDECJ 4@?5:E:@?D 2?5 4@>A6E:E:@?j 86?6C2= 64@?@>:4 724E@CD[ :?4=F5:?8 :?E6C6DE C2E6 2?5 4FCC6?4J 6I492?86 C2E6 7=F4EF2E:@?Dj E96 :>A24E @7 A92C>246FE:42= :?5FDECJ C68F=2E:@? 2?5 962=E9 42C6 =68:D=2E:@? :? !]#]r9:?2[ kDA2? 4=2DDlQI?\=@42E:@?QmE96 &?:E65 $E2E6Dk^DA2?m 2?5 :?E6C?2E:@?2==Jj 8=@32= EC6?5D E@H2C5 962=E9 42C6 4@DE 4@?E2:?>6?Ej E649?@=@8:42= 25G2?46D[ ?6H AC@5F4ED 2?5 A2E6?ED 2EE2:?65 3J 4@>A6E:E@CDj 492==6?86D :?96C6?E :? ?6H AC@5F4E 56G6=@A>6?E[ :?4=F5:?8 @3E2:?:?8 C68F=2E@CJ 2AAC@G2=j p<6D@VD 23:=:EJ E@ 244FC2E6=J AC65:4E 7FEFC6 >2C<6E 4@?5:E:@?Dj >2?F724EFC:?8 5:77:4F=E:6D @C 56=2JDj 7:?2?4:2= :?DE23:=:EJ @7 :?E6C?2E:@?2= 64@?@>:6D 2?5 D@G6C6:8? C:D<j 56A6?56?46 @? E96 67764E:G6?6DD @7 E96 p<6D@VD A2E6?ED 2?5 @E96C AC@E64E:@?D 7@C :??@G2E:G6 AC@5F4EDj 2?5 E96 6IA@DFC6 E@ =:E:82E:@?[ :?4=F5:?8 A2E6?E =:E:82E:@?[ 2?5^@C C68F=2E@CJ 24E:@?D]k^Am
kAmp<6D@ 5@6D ?@E F?56CE2<6 2?J @3=:82E:@? E@ AF3=:4=J C6G:D6 E96D6 7@CH2C5\=@@<:?8 DE2E6>6?ED E@ C67=64E 6G6?ED @C 4:C4F>DE2?46D 27E6C E96 52E6 96C6@7[ 6I46AE 2D C6BF:C65 3J =2H]k^Am
kAmkDEC@?8mp3@FE p<6D@k^Am
kAmk^DEC@?8mk^Am
kAmp<6D@ Wwzt)i hhae]wzX :D 2 =625:?8 3:@A92C>246FE:42= 4@>A2?J 4@>>:EE65 E@ E96 C6D62C49[ 56G6=@A>6?E[ >2?F724EFC:?8 2?5 4@>>6C4:2=:K2E:@? @7 E96 H@C=5VD 7:CDE @C 36DE\:?\4=2DD :??@G2E:G6 3:@=@8:42= >65:4:?6D] u@F?565 :? a_`a[ E96 4@>A2?J 92D 4C62E65 2 F?:BF6 :?E68C2E65 #U2>Ajs :??@G2E:@? DJDE6> H:E9 E96 4@>AC696?D:G6 6?5\E@\6?5 5CF8 56G6=@A>6?E A=2E7@C> Wprt !=2E7@C>X 2?5 3:\DA64:7:4 2?E:3@5J 5CF8 56G6=@A>6?E E649?@=@8J W%6EC23@5JX 2D E96 4@C6[ 2 v|!\4@>A=:2?E >2?F724EFC:?8 DJDE6> 2?5 2 4@>>6C4:2=:K2E:@? DJDE6> H:E9 2? 25G2?465 @A6C2E:@? >@56[ 2?5 92D 8C25F2==J 56G6=@A65 :?E@ 2 8=@32==J 4@>A6E:E:G6 3:@A92C>246FE:42= 4@>A2?J 7@4FD65 @? :??@G2E:G6 D@=FE:@?D] (:E9 7F==J :?E68C2E65 >F=E:\7F?4E:@?2= A=2E7@C>[ p<6D@ :D :?E6C?2==J H@C<:?8 @? 2 C@3FDE A:A6=:?6 @7 @G6C d_ :??@G2E:G6 2DD6ED :? E96 7:6=5D @7 42?46C[ 2FE@:>>F?6 5:D62D6[ :?7=2>>2E:@?[ >6E23@=:4 5:D62D6 2?5 @E96C >2;@C 5:D62D6D] p>@?8 E96>[ ac 42?5:52E6D 92G6 6?E6C65 4=:?:42= EC:2=D W:?4=F5:?8 `d 3:DA64:7:4^>F=E:DA64:7:4 2?E:3@5:6D 2?5 3:DA64:7:4 psrD] p55:E:@?2==J[ f ?6H 5CF8D 2C6 4@>>6C4:2==J 2G2:=23=6[ 2?5 a ?6H 5CF8D H:E9 a ?6H :?5:42E:@?D 2C6 F?56C C68F=2E@CJ C6G:6H 7@C 2AAC@G2=] %9C@F89 677:4:6?E 2?5 3C62<E9C@F89 #U2>Ajs :??@G2E:@?[ p<6D@ 2=H2JD :?E68C2E6D DFA6C:@C 8=@32= C6D@FC46D[ 56G6=@AD E96 7:CDE\:?\4=2DD 2?5 36DE\:?\4=2DD ?6H 5CF8D[ AC@G:56D 277@C523=6 E96C2A6FE:4 2?E:3@5:6D 7@C A2E:6?ED H@C=5H:56[ 2?5 4@?E:?F@FD=J 4C62E6D >@C6 4@>>6C4:2= 2?5 D@4:2= G2=F6D E@ 364@>6 2 8=@32= =625:?8 3:@A92C>246FE:42= 6?E6CAC:D6]k^Am
kAmu@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:E kDEC@?8mk2 9C67lQ9EEADi^^HHH]2<6D@3:@]4@>^6?^23@FE\FD^4@CA@C2E6\AC@7:=6^Q C6=lQ?@7@==@HQ E2C86ElQ03=2?<Qm9EEADi^^HHH]2<6D@3:@]4@>^6?^23@FE\FD^4@CA@C2E6\AC@7:=6^k^2mk^DEC@?8m 2?5 7@==@H FD @? kDEC@?8mk2 9C67lQ9EEADi^^HHH]=:?<65:?]4@>^4@>A2?J^2<6D@\3:@^A@DED^n7665':6Hl2==Q C6=lQ?@7@==@HQ E2C86ElQ03=2?<Qm{:?<65:?k^2mk^DEC@?8m]k^Am
kA :5lQ!&#{Qmk:>8 2=ElQr:D:@?Q 96:89ElQ`aQ DC4lQ9EEADi^^4a`a]?6E^4^:>8^72G:4@?]A?8nD?lr}b`ageU2>AjD5la_ad\_f\`dQ E:E=6lQr:D:@?Q H:5E9lQ`aQ ^m ':6H @C:8:?2= 4@?E6?Eik2 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2<6D@\2??@F?46D\7:CDE\A2E:6?E\6?C@==65\:?\E96\A92D6\:::\EC:2=2<``a\b`a92C>@?:\8:e@7\:G@?6D4:>23\7@C\7:CDE\=:?6\EC62E>6?E\@7\25G2?465\>6E2DE2E:4\4@=@C64E2=\42?46C\b_ad_eacg]9E>=Q :5lQ!#}&#{Q C6=lQ?@7@==@HQ E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2<6D@\2??@F?46D\7:CDE\A2E:6?E\6?C@==65\:?\E96\A92D6\:::\EC:2=2<``a\b`a92C>@?:\8:e@7\:G@?6D4:>23\7@C\7:CDE\=:?6\EC62E>6?E\@7\25G2?465\>6E2DE2E:4\4@=@C64E2=\42?46C\b_ad_eacg]9E>=k^2mk^Am
kAm$~&#rt p<6D@[ x?4]k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}b`ageU2>Aj%C2?D>:DD:@?0x5la_ad_f`da`cf!#0}t($0&$!#00000r}b`ageU2>Ajs2E6x5la_ad_f`dQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us.